Public Accounts Committee: Inquiry on roll out of the Covid-19 vaccine programme
We welcome the Committee’s call for evidence into the rollout of the COVID-19 vaccination programme. Our response offers the experiences...
We welcome the Committee’s call for evidence into the rollout of the COVID-19 vaccination programme. Our response offers the experiences...
We welcome the opportunity to contribute to the DHSC’s second consultation on hub and spoke dispensing. We are currently reviewing...
The Company Chemists’ Association (CCA) is disappointed that the Pharmacist Defence Association (PDA) continue to claim that the very real...
The CCA responded to the Scottish Health, Social Care and Sport Committee’s inquiry into Alternative Pathways to Healthcare. In our...
Over the last 5 years an alarming shortfall of over 3,000 community pharmacists has developed in England. Pharmacies are struggling...
The CCA is aware of discrepancies in data used to identify the number of pharmacists in the community pharmacy workforce...
On the appointment of Janet Morrison OBE as PSNC’s new Chief Executive, Malcolm Harrison, Chief Executive of the CCA said:...
We welcome this investment from the NHS E/I. It is a positive step towards the greater integration of community pharmacy...
The CCA welcomes the opportunity to respond to the consultation on Violence against women, domestic abuse and sexual violence (VAWDASV)...
We were pleased to submit evidence to the General Pharmaceutical Council’s consultation on remote hearings. Click here to download the...
In recent years, the CCA has become increasingly concerned about growing pressures on the community pharmacy workforce and its impact...
The CCA submitted comments to NICE’s draft guidelines on vaccine uptake in the general population. In our response, we highlight...